AP NEWS

Cold Chain Logistics Market for Healthcare Report 2018: Focus on Cell Therapies, Vaccines, and Human Organs, 2018-2030 - ResearchAndMarkets.com

November 23, 2018

DUBLIN--(BUSINESS WIRE)--Nov 23, 2018--The “Cold Chain Logistics Market for Healthcare: Focus on Cell Therapies, Vaccines, and Human Organs, 2018-2030” report has been added to ResearchAndMarkets.com’s offering.

The Cold Chain Logistics Market for Healthcare: Focus on Cell Therapies, Vaccines, and Human Organs, 2018-2030′ report features an extensive study of the current landscape and future outlook of the growing cold chain logistics services market. The study features an in-depth analysis, highlighting the capabilities of the various service providers engaged in this domain.

The origins of the cold chain for transportation of temperature sensitive products can be traced back to 1797, when British fishermen first used natural ice to preserve their fish stock. Presently, a wide variety of pharmaceutical products, such as biologics, vaccines, human organs for transplantation and certain conventional pharmacological interventions as well, are temperature sensitive and require freezing / cryogenic holding temperatures for transport.

In fact, over 95% of all approved biologics and 90% of all vaccines are cold chain dependent. Other healthcare products which are required to be shipped/stored under specific temperature conditions include aerosols, blood plasma samples, certain types of diagnostics kits, fertility samples, and laboratory specimens. For some products, even the slightest variations in temperature/storage conditions can adversely alter their integrity and/or viability.

Over the years, the growing demand for such products has necessitated the need for well-defined infrastructure and protocols to support cold chain dependent logistics operations. Further, stakeholders in this segment of the industry have designed and established a variety of innovative solutions to serve the evolving demands of the healthcare sector. Moreover, connected cold chain solutions have been observed to offer a variety of advantages over conventional methodologies, such as automation of most of the steps and elimination of human handling errors that are associated with human intervention.

In addition, the industry has witnessed several facility/capability expansions and acquisitions owing to an increasing demand for cold chain logistics services, which is indicative of the growing interest of stakeholders in this particular type of supply chain. Given the recent technological breakthroughs and advances, and the steadily rising demand for biopharmaceuticals, the reliance on cold chain is expected to increase substantially, causing logistics service providers to contemplate, devise and implement flexible business strategies and operational models to cope up with the future needs.

One of the key objectives of the report was to estimate the existing market size and potential growth opportunities for cold chain logistics over the coming decade. Based on several parameters, we have provided an informed estimate of the likely evolution of this market in the short to mid-term and long-term, for the period 2018-2030.

Upcoming Trends And Future Growth Opportunities

Connected Cold Chain: Key Tools And Technologies

Artificial Intelligence Augmented Reality Automation and Robotics Big Data Analytics Blockchain Technology Cloud Computing Internet of Things Radio Frequency Identification (RFID) Tags

Connected Cold Chain: Future Growth Opportunities

Real-Time Monitoring: An Application of Connected Cold Chain Solutions

Methods for Integration of Real-Time Monitoring in Cold Chain Logistics RFID Based Real-Time Monitoring Blockchain and IoT Based Real-Time Monitoring Growth Opportunities for Real-Time Monitoring in Connected Cold Chain Cost Benefits of Real-Time Monitoring in Cold Chain Logistics

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Cold Chain Logistics For Cell Therapies, Vaccines And Human Organs

5. Market Landscape

6. Company Competitiveness Analysis

7. Company Profiles

8. Recent Partnerships And Expansions

9. Regulatory Recommendations And Guidelines

10. Case Study: Cold Chain Requirements For Approved Drugs

11. Demand Analysis For Cell Therapies

12. Demand Analysis For Vaccines

13. Demand Analysis For Human Organs

14. Market Forecast

15. SWOT Analysis

16. Upcoming Trends And Future Growth Opportunities

17. Executive Insights

18. Appendix 1: Tabulated Data

19. Appendix 2: List Of Companies And Organizations

For more information about this report visit https://www.researchandmarkets.com/research/59sshs/cold_chain?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181123005063/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Logistics,Industrial Refrigeration

KEYWORD:

INDUSTRY KEYWORD: TRANSPORT HEALTH LOGISTICS/SUPPLY CHAIN MANAGEMENT MEDICAL SUPPLIES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/23/2018 05:24 AM/DISC: 11/23/2018 05:24 AM

http://www.businesswire.com/news/home/20181123005063/en

AP RADIO
Update hourly